Welcome to the Applied Clinical Trials eShow Daily coming from the floor of the DIA 18th Annual EuroMeeting in Paris, France.
Welcome to the Applied Clinical Trials eShow Daily coming from the floor of the DIA 18th Annual EuroMeeting
in Paris, France.
Watch your email box for digests of the meetings most important and pertinent clinical news-gathered from sessions, press briefings and the exhibit hall.
Whether you are live at the 2006 DIA EuroMeeting this week or you are elsewhere, we hope you benefit from our daily coverage.
Do you have colleagues
and associates who
are not receiving
Applied Clinical Trials
E-Show Daily?
Have them log on to www.actmagazine.com
for the latest updates
from DIA.
Thank you, Toby J. Hindin, Editor-in-Chief.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
FDA Fast Tracks Johnson & Johnson’s Nipocalimab for Fetal Neonatal Alloimmune Thrombocytopenia
March 27th 2024Johnson & Johnson is moving forward with a pair of Phase III trials of nipocalimab to reduce the risk of fetal neonatal alloimmune thrombocytopenia in alloimmunized pregnant patients.